Iovance Biotherapeutics Inc (IOVA) — Cash Flow Quality Index
Latest as of June 2013:
1.92x
Iovance Biotherapeutics Inc (IOVA) has a Cash Flow Quality Index of 1.92x as of June 2013. Operating cash flow of $6.65 Million exceeds net income of $3.47 Million, indicating high earnings quality where cash backs reported profits. Explore Iovance Biotherapeutics Inc cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
1.92x
Operating CF / Net Income
Operating Cash Flow
$6.65 Million
USD
Net Income
$3.47 Million
USD
Data as of
Jun 2013
Most recent filing
Annual Cash Flow Quality Index for Iovance Biotherapeutics Inc (None–None)
Year-by-year earnings quality comparison for Iovance Biotherapeutics Inc.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.